Showing results (241-250 of 6,279) with videos related to

Sort By:
Pageof 628
Diabetes, Obesity & Metabolism|August 20, 2025
Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP-1R/GIPR dual agonist, HISHS-2001Yusman Manchanda, Ben Jones, Gaelle Carrat, et al.
Diabetes, Obesity & Metabolism|August 22, 2025
Efficacy and safety of chiglitazar add-on to metformin in type 2 diabetes mellitus (RECAM study)Leili Gao, Linong Ji, Xin Yan, et al.
Diabetes, Obesity & Metabolism|August 22, 2025
Hybrid closed-loop systems in UK type 1 diabetes care: National survey of healthcare professional awareness, confidence, and training needsAnanthi Anandhakrishnan, Alexandros L Liarakos, Ketan Dhatariya, et al.
Diabetes, Obesity & Metabolism|February 9, 2026
Oxidised lipoproteins and the risk of type 2 diabetes mellitus: A 5-year cohort study on β-cell dysfunction and prediabetes progressionJun-Xu Gu, Juan Huang, Ai-Min Zhang, et al.
Diabetes, Obesity & Metabolism|February 3, 2026
Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trialSo Ra Kim, Jun Hwa Hong, Sin Gon Kim, et al.
Diabetes, Obesity & Metabolism|February 2, 2026
Interactive online calculator for estimation of muscle and hepatic insulin sensitivity in adults with Type 1 diabetes using clinical and research biomarkersAndrzej S Januszewski, Jennifer R Snaith, Greg M Kowalski, et al.
Diabetes, Obesity & Metabolism|February 2, 2026
Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetesYing Wei, Yong Tian, Ruixiang Cui, et al.
Diabetes, Obesity & Metabolism|February 9, 2026
Impact of conventional lipid-lowering therapy on circulating levels of proprotein convertase subtilisin/kexin type 9: A systematic review and meta-analysis of randomised controlled trialsLingyan Meng, Tianze Huang, Shuaiwei Guo, et al.
Diabetes, Obesity & Metabolism|February 10, 2026
RETRACTION: Effects of GLP-1 Receptor Agonists on Cognitive Function in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
Diabetes, Obesity & Metabolism|February 9, 2026
Neuroprotective effects of semaglutide targeting the left temporal lobe in adults with overweight or obesity: A 24-week multimodal neuroimaging studyFanhua Meng, Xiang Ao, Xiangming Lin, et al.
Pageof 628